Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Abbott narrows 2012 guidance, announces more layoffs and tempers M&A outlook
Abbott’s stock slides more than 4% following a narrowed earnings outlook for 2012, news of more layoffs and a "nothing big" strategy for mergers and acquisitions.
2. Diabetes: Europe, the U.S. and the medtech pendulum’s swing
Medtech veteran Christopher Jones, the CEO of medical device company GlySure, tellsMassDevice.com about his experiences in the U.S. and across the pond, with some words of guidance for companies pursuing a Europe-1st strategy.
1. St. Jude Medical slides on potential FDA warning, lowered outlook
Shares of St. Jude Medical are down more than 6% today after the medical device company said it might get a warning letter from the FDA over a California plant and lowered its outlook for the rest of the year.
